Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - St. Joseph Mercy Oakland

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Fibromyalgia
Interventions
DEVICE

RINCE

The intervention uses the NeuroPoint device to deliver repeat applications of RINCE therapy stimulation. The sham uses the NeuroPoint device, but the RINCE therapy stimulation is not turned on.

Trial Locations (1)

48431

St. Joseph Mercy Oakland, Pontiac

Sponsors
All Listed Sponsors
lead

Cerephex Corporation

INDUSTRY

NCT01825954 - Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - St. Joseph Mercy Oakland | Biotech Hunter | Biotech Hunter